In the same manner, administration of siRNA-STAT1 to monocytes/macrophages using dendrimeric NPs as a delivery tool inhibits the IFN-mediated inflammation that occurs during systemic lupus erythematosus (SLE). Here, STAT1 is linked to systemic lupus erythematosus.